Protective effects of dietary phytoestrogens in chronic renal disease

Journal of Renal Nutrition

Volumn 11, Issue 4, 2001, Pages 183-193

  Ranich, Tedine ^a   Bhathena, Sam J ^b   Velasquez, Manuel T ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; GLYCINE MAX;

ESTROGEN; ISOFLAVONE DERIVATIVE; LIGNAN; PHYTOESTROGEN; PLANT MEDICINAL PRODUCT; SOYBEAN PROTEIN; VEGETABLE PROTEIN;

ANIMAL; CHEMISTRY; CHRONIC KIDNEY FAILURE; DISEASE COURSE; FLAX; HUMAN; REVIEW; SAFETY; TREATMENT OUTCOME;

ANIMALS; DISEASE PROGRESSION; ESTROGENS, NON-STEROIDAL; FLAX; HUMANS; ISOFLAVONES; KIDNEY FAILURE, CHRONIC; LIGNANS; PHYTOESTROGENS; PLANT PREPARATIONS; PLANT PROTEINS; SAFETY; SOYBEAN PROTEINS; TREATMENT OUTCOME;

EID: 0035490582     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/jren.2001.26975     Document Type: Review

References (93)

1. Giovanetti S, Maggiore Q: A low nitrogen diet with protein of high biological value for severe chronic uremia. Lancet 1:1000-1003, 1964
2. Berlyne GM, Shaw AB, Nilwarangkur S: Dietary treatment of chronic renal failure. Experience with a modified Giovanetti diet. Nephron 2:129-147, 1965
3. Kopple JD, Coburn JW: Metabolic studies of low protein diets in uremia. I. Nitrogen and potassium. Medicine 52:583-595, 1973
4. Barsotti G: Effects of dietary therapy on urmeic symptoms and complications, in Giovannetti S (ed): Nutritional Therapy of Chronic Renal Failure. Boston, MA, Kluwer Academic, 1989, pp 235-240
5. Mitch WE, Walser M: Nutritional therapy of the uremic patient, Brenner BM (ed): in The Kidney (ed 5). Philadelphia, PA, Saunders, 1996, pp 2382-2423
6. Walser M, Mitch WE, Maroni BJ, et al: Should protein intake be restricted in pre dialysis patients. Kidney Int 55:771-779, 1999
7. Brenner BM, Meyer TW, Hostetter TH: Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis of aging, renal ablation, and intrinsic renal disease. N Engl J Med 307:652-659, 1982
8. Klahr S, Buerkert J, Purkerson ML: Role of dietary factors in the progression of chronic renal disease. Kidney Int 24:579-587, 1983
9. Rosman JB, ter Wee PM, Meijer S, et al: Prospective randomized trial of early dietary protein restriction in chronic renal failure. Lancet 2:1291-1296, 1984
10. Mitch WE, Walser M, Steinman TL, et al: The effect of a ketoacid-amino acid supplement to a restricted diet on the progression of chronic renal failure. N Engl J Med 311:623-629, 1984
11. Ihle BU, Becker GJ, Whitworth JA, et al: The effect of protein restriction on the progression of renal insufficiency. N Engl J Med 321:1773-1777, 1989
12. Walker JD, Dodds RA, Murrells TJ, et al: Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet 2:1411-1414, 1989
13. Zeller KR: Low protein diets in renal disease. Diabetes Care 14:856-66, 1991
14. Fouque D, Laville M, Boissel JP, et al: Controlled low protein diets in chronic renal insufficiency: Meta-analysis. BMJ 304:216-220, 1992
15. Pedrini MT, Levey AS, Lau J, et al: The effects of dietary protein restriction on the progression of diabetic and non-diabetic renal disease: A meta-analysis. Ann Intern Med 124:627-632, 1996
16. Williams AJ, Walls J: Metabolic consequences of differing protein diets in experimental renal disease. Eur J Clin Invest 17:117-122, 1987
17. Williams AJ, Baker F, Walls J: Effect of varying quantity and quality of dietary protein intake in experimental renal disease in rats. Nephron 46:83-90, 1987
18. Barsotti G, Navalesi R, Giampietro O, et al: Effects of a vegetarian, supplemented diet on renal function, proteinuria, and glucose metabolism in patients with "overt" diabetic nephropathy and renal insufficiency. Contrib Nephrol 65:87-94, 1988
19. Jibani MM, Bloodworth LL, Foden E, et al: Predominantly vegetarian diet in patients with incipient and early clinical diabetic nephropathy: Effects on albumin excretion rate and nutritional status. Diabet Med 8:949-953, 1991
20. Wardle EN: Soy protein diet therapy in renal disease. Nephron 78:328-331, 1998
21. Iwasaki K, Gleiser CA, Masoro EJ, et al: The influence of dietary protein source on longevity and age-related disease processes of Fischer rats. J Gerontol 43:B5-B12, 1988
22. Shimokawa I, Higami Y, Hubbard GB, et al: Diet and the suitability of the male Fischer 343 rat as a model for aging research. J Gerontol 48:B27-B32, 1993
23. Tomobe K, Philbrick DJ, Ogborn MR, et al: Effect of dietary soy protein and genistein on disease progression in mice with polycystic kidney disease. Am J Kidney Dis 31:55-61, 1998
24. Aukema HM, Housini I, Rawling JM: Dietary soy protein effects on inherited polycystic kidney disease are influenced by gender and protein level. J Am Soc Nephrol 10:300-308, 1999
25. Ogborn MR, Bankovic-Calic N, Shoesmith C, et al: Soy protein modification of rat polycystic kidney disease. Am J Physiol 274(3Pt2):F541-F549, 1998
26. Ogborn MR, Nitschmann E, Weiler HA, et al: Modification of polycystic kidney disease and fatty acid status by soy protein diet. Kidney Int 57:159-166, 2000
27. D'Amico G, Gentile MG, Manna G, et al: Effect of vegetarian soy diet on hyperlipidaemia in nephrotic syndrome. Lancet 339:1131-1134, 1992
28. Gentile MG, Fellin G, Cofano F, et al: Treatment of proteinuric patients with a vegetarian soy diet and fish oil. Clin Nephrol 40:315-320, 1993
29. Soroka N, Silverberg DS, Greemland M, et al: Comparison of a vegetable-based (soya) and an animal-based low-protein diet in predialysis chronic renal failure patients. Nephron 79:173-180, 1998
30. Anderson JW, Blake JE, Turner J, et al: Effects of soy protein on renal function and proteinuria in patients with type 2 diabetes. Am J Clin Nutr 68:13475-13535, 1998 (Suppl 6)
31. Hall AV, Parbtani A, Clark WF, et al: Abrogation of MRL/lpr lupus nephritis by dietary flaxseed. Am J Kidney Dis 22:326-332, 1993
32. Theofilopolous AN, Dixon FJ: Murine models of systemic lupus erythematosus. Adv Immunol 37:269-290, 1985
33. Ingram AJ, Parbtani A, Clark WF, et al: Effects of flaxseed and flax oil diets in a rat-5/6 renal ablation model. Am J Kidney Dis 25:320-329, 1995
34. Ogborn MR, Nitschmann E, Weiler H, et al: Flaxseed ameliorates interstitial nephritis in rat polycystic kidney disease. Kidney Int 55:417-423, 1999
35. Clark WF, Parbtani A, Huff MW, et al: Flaxseed: A potential treatment for lupus nephritis. Kidney Int 48:475-480, 1995
36. Martin PM, Horwitz KB, Ryan DS, et al: Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 103:1860-1867, 1978
37. Miksicek RJ: Interaction of naturally occurring non-steroidal estrogens with expressed with recombinant human estrogen receptor. J Steroid Biochem Mol Biol 49:153-160, 1994
38. Ros Barcelo A: Lignification in plant cell walls, in Jeon KW (ed): International Review of Cytology, vol 176. San Diego, CA, Academic, 1997, pp 87-132
39. Axelson M, Sjovall J, Gustafsson B, et al: Soya - A dietary source of the non-steroidal oestrogen equol in humans and animals. J Endocrinol 102:49-56, 1984
40. Coward L, Barnes NC, Setchell KDR, et al: Genistein and daidzein, and their β-glycoside conjugates: Anti-tumor isoflavones in soy bean foods from American and Asian diets. J Agric Food Chem 41:1961-1967, 1993
41. Wang H-J, Murphy PA: Isoflavone content in commercial soybean foods. J Agric Food Chem 42:1666-1673, 1994
42. Wang H-J, Murphy PA: Isoflavone composition of American and Japanese soybean in Iowa: Effects of variety, crop year, and location. J Agric Food Chem 42:1674-1677, 1994
43. Haytowitz DB, Matthews RH: Legumes and Legume Products. Washington, DC, United States Department of Agriculture, 1986, pp 1-156
44. Young VR: Soy protein in relation to human protein and amino acid nutrition. J Am Diet Assoc 91:828-835, 1991
45. Thompson LU, Robb P, Serraino M, et al: Mammalian lignan production from various foods. Nutr Cancer 16:43-52, 1991
46. Thompson LU, Rickard SE, Cheung F, et al: Variability in anticancer lignan levels in flaxseed. Nutr Cancer 27:26-30, 1997
47. Mazur W, Fotsis T, Wahala K, et al: Isotope dilution gas chromatographic-mass spectrometric method for the determination of isoflavonoids, coumestrol, and lignans in food samples. Anal Biochem 233:169-180, 1996
48. Slavin JL, Jacobs D, Marquart L: Grain processing and nutrition. Crit Rev Food Sci Nutr 40:309-326, 2000
49. Setchell KDR, Adlercreutz H: Mammalian lignans and phyto-estrogens. Recent studies on their formation, metabolism and biologic role in health and disease, in Rowland I (ed): Role of the Gut Flora in Toxicity and Cancer. Basel, Switzerland, Karger, 1988, pp 315-345
50. Borriello SP, Setchel KDR, Axelson M: Production and metabolism of lignans by the human faecal flora. J Appl Bacteriol 58:37-43, 1985
51. Axelson M, Setchell KDR: The excretion of lignans in rats: evidence for an intestinal bacterial source for this new group of compounds. FEBS Lett 123:337-342, 1981
52. Rowland IR, Wiseman H, Sanders TA, et al: Interindividual variation in metabolism of soy isoflavones and lignans: Influence of habitual diet on equol production by the gut microflora. Nutr Cancer 36:27-32, 2000
53. Morton MS, Wilcox G, Wahlgvist ML, et al: Determination of lignans and isoflavonoids in human female plasma following dietary supplementation. J Endocrinol 142:251-259, 1994
54. Adlercreutz H, Fotsis T, Lampe J, et al: Quantitative determination of lignans and isoflavones in plasma of omnivorous and vegetarian women by isotope-dilution gas chromatography-mass spectrometry. Scand J Clin Lab Invest 53:5-18, 1993 (suppl 215)
55. Adlercreutz H, Markkanen H, Watanabe S: Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 342: 1209-1210, 1993
56. Nesbitt PD, Lam Y, Thompson LU: Human metabolism of mammalian lignan precursors in raw and processed flaxseed. Am J Clin Nutr 69:549-555, 1999
57. Lampe JW, Martini MC, Kurzer MS, et al: Urinary lignan and isoflavonoid excretion in premenopausal women consuming flaxseed powder. Am J Clin Nutr 60:122-128, 1994
58. Cunnane SC, Hamadeh MJ, Liede AC, et al: Nutritional attributes of traditional flaxseed in healthy young adults. Am J Clin Nutr 61:62-68, 1995
59. Rickard SE, Orcheson LJ, Seidl MM, et al: Dose-dependent production of mammalian lignans in rats and in vitro from the purified precursor secoisolariciresinol diglycoside in flaxseed. J Nutr 126:2012-2019, 1996
60. Setchell KDR: Phytoestrogens: The biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 68:13335-13485, 1998
61. Tham DM, Gardner CD, Haskell WL: Potential health benefits of dietary phytoestrogens: A review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab 83:2223-2235, 1998
62. Markiewicz L, Garey J, Adlercreutz H, et al: In vitro bioassays of non-steroidal phytoestrogens. J Steroid Biochem Mol Biol 45:399-405, 1993
63. Kuiper GGJM, Lemmen JG, Carlsson B, et al: Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139:4252-4263, 1998
64. Taylor AH, Al-Azzawi F: Immunolocalisation of oestrogen receptor beta (ERβ) in human tissues. J Mol Endocrinol 24:145-155, 2000
65. Hirano T, Fukuoka K, Oka K, et al: Antiproliferative activity of mammalian lignan derivatives against the human breast carcinoma cell line, ZR-75-1. Cancer Invest 8:595-601, 1990
66. Serraino M, Thompson LU: The effect of flaxseed supplementation on the initiation and promotional stages of mammary tumorigenesis. Nutr Cancer 17:153-159, 1992
67. Peterson G, Coward L, Barnes S: Isoflavones inhibit the growth of human prostate cancer cells in culture. Proc Am Assoc Cancer Res 33:57-64, 1992
68. Yanajihara K, Ito A, Toge T, et al: Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res 53:5815-5821, 1993
69. Zava DT, Duwe G: Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 27:31-40, 1997
70. Wang TTY, Sathyamoorthy N, Phang JM: Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 17:271-275, 1996
71. Fotsis T, Pepper M, Adlercreutz H, et al: Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci U S A 90:2690-2694, 1993
72. Akiyama T, Ishida J, Nakagawa S, et al: Genistein, a specific inhibitor of tyro sine-specific protein kinases. J Biol Chem 262:5592-5595, 1987
73. Linassier C, Pierre M, LePecq JB, et al: Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity. Biochem Pharmacol 39:187-193, 1990
74. Okura A, Arakawa H, Oka H, et al: Effect of genistein on topoisomerase activity and on the growth of [Val 12] Ha-ras-transformed NIH 3T3 cells. Biochem Biophys Res Commun 157:183-189, 1988
75. Markovits J, Linassier C, Fosse P, et al: Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res 49:5111-5117, 1989
76. Kim H, Peterson TG, Barnes S: Mechanisms of action of the soy isoflavone genistein: Emerging role for its effects via transforming growth factor β signaling pathways. Am J Clin Nutr 68:1418S-1425S, 1998 (suppl)
77. Wei HC, Wei LH, Frenkel K, et al: Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutr Cancer 20:1-12, 1993
78. Wei HC, Bowen R, Cai Q, et al: Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med 208:124-130, 1995
79. Record IR, Dreosti IE, Mclnerney JK: The antioxidant activity of genistein in vitro. J Nutr Biochem 6:481-485, 1995
80. Kitts DD, Yuan YV, Wijewickreme AN, et al: Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metablites enterodiol and enterolactone. Mol Cell Biochem 202:91-100, 1999
81. Vedavanam K, Srijayanta S, O'Reilly J, et al: Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soyabean phytochemical extract (SPE). Phytother Res 13:601-608, 1999
82. Nakashima S, Koike T, Nozawa Y: Genistein, a protein tyrosine kinase inhibitor, inhibits thromboxane A2-mediated human platelet responses. Mol Pharmacol 39:475-480, 1991
83. Asahi M, Yanagi S, Ohta S, et al: Thombin-induced human platelet aggregation is inhibited by protein tyrosine-kinase inhibitors, ST638 and genistein. FEBS Lett 309:10-14, 1992
84. Rendu F, Eldor A, Grelac F, et al: Inhibition of platelet activation by tyrosine kinase inhibitors. Biochem Pharmacol 44:881-888, 1992
85. McNicol A: The effects of genistein on platelet function are due to thromboxane receptor antagonism rather than inhibition of tyrosine kinase. Prostaglandins Leukot Essent Fatty Acids 48:379-384, 1992
86. Shen TY, Hussaini IM: Kadsurenone and other related lignans as antagonists of platelet-activating factor receptor. Methods Enzymol 187:446-454, 1990
87. Krol W, Czuba ZP, Threadgill MD, et al: Inhibition of nitric oxide (NO) production in murine macrophages by flavones. Biochem Pharmacol 50:1031-1035, 1995
88. Atluru D, Gudapaty S: Inhibition of bovine mononuclear cell proliferation, interleukin-2 synthesis, protein-tyrosine kinase and leukotiene-B(4) production by a protein-tyrosine kinase inhibitor, genistein. Vet Immunol Immunopathol 38:113-122, 1993
89. Hirakata M, Kaname S, Chung UG, et al: Tyrosine kinase dependent expression of TGF-beta induced by stretch in mesangial cells. Kidney Int 51:1028-1036, 1997
90. Kato H, Osajima A, Uezono Y, et al: Involvement of PDGF in pressure-induced mesangial cell proliferation through PKC and tyrosine kinase pathways. Am J Physiol 277 (1Pt2): F105-F112, 1999
91. Ha H, Roh DD, Kirschenbaum MA, et al: Atherogenic lipoproteins enhance mesangial cell expression of platelet-derived growth factor: role of protein tyrosine kinase and cyclic AMP-dependent protein kinase. J Lab Clin Med 131:456-465, 1998
92. Yokoo T, Kitamura M: Dual regulation of IL-1β-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-kB and AP-1. Am J Physiol 270 (1 Pt 2):F123-F130, 1996
93. Coyne DW, Morrison AR: Effect of tyrosine kinase inhibitor, genistein, on interleukin-1 stimulated PGE2 production in mesangial cells. Biochem Biophys Res Commun 73:718-724, 1990.